Shares of Arena Pharmaceuticals (NASDAQ: ARNA), a small-cap biopharmaceutical company, gained as much as 19.2% in early morning trading today. The catalyst behind this sizable move northward was the ...

Christopher Petzel, a director at Arena Group Holdings, Inc. (NYSE: AREN), has sold 25,010 shares of the company's common stock. The transaction comes as the stock has shown strong momentum, with ...

On Friday, Sports Illustrated owner Authentic Brands Group stated that they’ve revoked Arena Group’s license to manage SI’s media operations following a missed payment of $3.75 million. That led to ...

The Arena Group Holdings, Inc. (AMEX:AREN) shares jumped premarket on Friday after the company delivered the first quarter of positive net income. Arena, which is home to hundreds of media brands, ...

According to data fromS&P Global Market Intelligence, shares of Arena Pharmaceuticals (NASDAQ: ARNA) dropped by 8.75% in March. Interestingly enough, though, the biotech's stock slumped last month ...

This rise is primarily attributable to a definitive agreement entered by Arena last month with Pfizer PFE, wherein the latter will acquire the former in an all-cash transaction for $100 per share or a ...

Arena Pharmaceuticals has posted positive data from a phase 2 trial of its pulmonary arterial hypertension (PAH) candidate ralinepag. The trial linked ralinepag to improvements in pulmonary vascular ...

Arena Holdings, a company that has been navigating through a challenging market, saw its stock plunge to a 52-week low, touching down at $0.58. This significant drop reflects a stark contrast to its ...